Early antiretroviral therapy and potent second-line drugs could decrease HIV incidence of drug resistance.
Ontology highlight
ABSTRACT: Early initiation of antiretroviral therapy (ART) reduces the risk of drug-sensitive HIV transmission but may increase the transmission of drug-resistant HIV. We used a mathematical model to estimate the long-term population-level benefits of ART and determine the scenarios under which earlier ART (treatment at 1 year post-infection, on average) could decrease simultaneously both total and drug-resistant HIV incidence (new infections). We constructed an infection-age-structured mathematical model that tracked the transmission rates over the course of infection and modelled the patients' life expectancy as a function of ART initiation timing. We fitted this model to the annual AIDS incidence and death data directly, and to resistance data and demographic data indirectly among men who have se
SUBMITTER: Shen M
PROVIDER: S-EPMC5489726 | biostudies-literature | 2017 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA